Adalimumab and Biosimilars

January 17, 2026

About Adalimumab [TNF inhibitor]

Adalimumab is an anti-TNF drug used for various types of arthritis. 

Adalimumab is used to treat various autoimmune conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn disease, and ulcerative colitis. Adalimumab is used off-label for various conditions, including: Neutrophilic dermatosis, specifically pyoderma gangrenosum.

Commercial Products

AttributesRD codeBrand NameApprovedOwnerAreaWebSite
OriginatorD2E7Humira®2002AbbVieUSAhumira.com
BiosimilarBAT1406QLETLI®2019BIO-THERA  (CNN:百奥泰)Chinabio-thera.com/col_53
BiosimilarHS016安健宁®2019HISUN Pharma(CNN:海正药业)Chinahisunpharm.com
BiosimilarIBI303SULINNO®
(CNN:苏立信®)
2020
InnoventBio(CNN:信达生物)
Chinainnoventbio.com
BiosimilarHLX03汉达远®2020Henlius (CNN:复宏汉霖)Chinahenlius.com
BiosimilarTQ-Z2301泰博维®2022CHIATHAI TIANQIONG(CNN:正大天晴药业)Chinacttq.com
BiosimilarUBP1211/9MW0113君迈康®2022Top Alliance (CNN:君实生物)Chinajunshipharma.com
BiosimilarSCT630安佳润2023SinoCellTech(CNN:神州细胞)ChinaSinocelltech.com
Biosimilar生爱宁2025SinoPharma(CNN:武汉生物)Chinawibp.com.cn

Business Cooperation

  • You wish to purchase this product (Adalimumab).
  • Do you want to obtain the distribution rights for this product (Adalimumab)?